NVSNovartis AG
Is the business good?
Margins widening. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
Customers and suppliers
Who buys from NVS and who it buys from, as the companies report it.
- Largest customer18%
Share of revenue · FY2025 20-F
- Second largest customer13%
Share of revenue · FY2025 20-F
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; NVS’s own figures are from its FY2025 20-F. Smaller customers and suppliers go unreported.
Drug Manufacturers, General
Ranks #2 of 7 by RyuScore